Shinji Nakamura

Prof. Shinji Nakamura

Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Shinji NakamuraShinji Nakamura
Shinji Nakamura
YNYasuhiro Nakao
Yasuhiro Nakao
YHYinmon Htun
Yinmon Htun
TMTsutomu Mitsuie
Tsutomu Mitsuie
KKKosuke Koyano
Kosuke Koyano
TKTakashi Kusaka
Takashi Kusaka
We previously reported the neuroprotective potential of combined hydrogen (H2) gas ventilation therapy and therapeutic hypothermia (TH) by assessing the short-term neurological outcomes and histological findings of 5-day neonatal hypoxic-ischemic (HI) encephalopathy piglets. However, the effects of H2 gas on cerebral circulation and oxygen metabolism and on prognosis were unknown. Here, we used near-infrared time-resolved spectroscopy to compare combined H2 gas ventilation and TH with TH alone. Piglets were divided into three groups: HI insult with normothermia (NT, n = 10), HI insult with hypothermia (TH, 33.5 ± 0.5 °C, n = 8), and HI insult with hypothermia plus H2 ventilation (TH + H2, 2.1–2.7%, n = 8). H2 ventilation and TH were administered and the cerebral blood volume (CBV) and cerebral hemoglobin oxygen saturation (ScO2) were recorded for 24 h after the insult. CBV was significantly higher at 24 h after the insult in the TH + H2 group than in the other groups. ScO2 was significantly lower throughout the 24 h after the insult in the TH + H2 group than in the NT group. In conclusion, combined H2 gas ventilation and TH increased CBV and decreased ScO2, which may reflect elevated cerebral blood flow to meet greater oxygen demand for the surviving neurons, compared with TH alone.

24 January 2024 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
TTToui Tsuchiya
Toui Tsuchiya
Shinji NakamuraShinji Nakamura
Shinji Nakamura
YSYuichiro Sugiyama
Yuichiro Sugiyama
YNYasuhiro Nakao
Yasuhiro Nakao
TMTsutomu Mitsuie
Tsutomu Mitsuie
TKTakashi Kusaka
Takashi Kusaka

Verified
Journal Article
Open access
PDF file
TKTakeo Kondo
Takeo Kondo
SKSonoko Kondo
Sonoko Kondo
NHNakayama-Imaohji Haruyuki
Nakayama-Imaohji Haruyuki
ATAyano Tada
Ayano Tada
NTNAFISA TABASSUM
NAFISA TABASSUM
TKTomomi Kuwahara
Tomomi Kuwahara
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease, are chronic disorders relating to gut microbiota dysbiosis. Despite severe pancolitis being more prevalent in pediatric UC than in adults, alterations in the colon mucosa-associated microbiota (MAM) and their association with disease severity remain to be elucidated. The present study aimed to compare the gut microbiota in colon lavage fluids (CLFs) and fecal samples from 19 pediatric UC and 19 non-IBD patients. The community structure of MAM inferred by 16S metagenomic analysis was similar throughout the colon regardless of disease type. Bacterial compositions between MAM and feces were significantly different in non-IBD, while no difference was observed in pediatric UC, indicating a compromised mucous layer that could not sufficiently separate the MAM and luminal microbiota in UC. In pediatric UC, homogenous distribution of MAM was gradually disordered with increases in disease activity or mucosal inflammation, and bacterial groups of upper digestive tract or environmental origin were more abundant in MAM. Monitoring key bacterial markers in MAM, which include Lactobacillus and Enterococcus or Faecalibacterium and Blautia as increased or reduced members in pediatric UC, respectively, might be useful for evaluation of patient prognosis.

1 August 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YNYasuhiro Nakao
Yasuhiro Nakao
Shinji NakamuraShinji Nakamura
Shinji Nakamura
YHYinmon Htun
Yinmon Htun
TMTsutomu Mitsuie
Tsutomu Mitsuie
KKKosuke Koyano
Kosuke Koyano
TKTakashi Kusaka
Takashi Kusaka
Perinatal hypoxic-ischemic brain injury of neonates remains a significant problem worldwide. During the resuscitation period, changes in cerebral hemoglobin oxygen saturation (ScO2) have been identified by near-infrared spectroscopy (NIRS). However, in asphyxiated neonates, the relationship between these changes and brain injury is not known. Three-wavelength near-infrared time-resolved spectroscopy, an advanced technology for NIRS, allows for the estimation of ScO2 and cerebral blood volume (CBV). Here, we studied changes in ScO2 and CBV during the resuscitation period after hypoxic-ischemic insult and the relationship between these changes after insult and histopathological brain injuries on day 5 after insult using an asphyxiated piglet model. Of 36 newborn piglets subjected to hypoxic-ischemic insult, 29 were analyzed. ScO2 and CBV were measured 0, 5, 10, 15, and 30 min after the insult. Brain tissue was histologically evaluated on day 5. ScO2 and CBV increased immediately after the insult, reached a peak, and then maintained a consistent value. The increase in CBV 5 to 30 min after the insult was significantly correlated with histopathological injury scores. However, there was no correlation with ScO2. In conclusion, an increase in CBV within 30 min after hypoxic-ischemic insult reflects the histopathological brain injury on day 5 after insult in a piglet model.

28 October 2020 in Neonatology
Verified
Journal Article
Closed access
PDF file
SYSatoshi Hamano Yamato
Satoshi Hamano Yamato
Shinji NakamuraShinji Nakamura
Shinji Nakamura
YHYinmon Htun
Yinmon Htun
MNMakoto Nakamura
Makoto Nakamura
WJWataru Jinnai
Wataru Jinnai
TKTakashi Kusaka
Takashi Kusaka
Background: Therapeutic hypothermia (TH) is a standard therapy for neonatal hypoxic-ischaemic encephalopathy. One potential additional therapy is the free radical scavenger edaravone (EV; 3-methyl-1-phenyl-2-pyrazolin-5-one). Objectives and Methods: This study aimed to compare the neuroprotective effects of edaravone plus therapeutic hypothermia (TH + EV) with those of TH alone after a hypoxic-ischaemic insult in the newborn piglet. Anaesthetized piglets were subjected to 40 min of hypoxia (3–5% inspired oxygen), and cerebral ischaemia was assessed using cerebral blood volume. Body temperature was maintained at 39.0 ± 0.5°C in the normothermia group (NT, n = 8) and at 33.5 ± 0.5°C (24 h after the insult) in the TH (n = 7) and TH + EV (3 mg/kg intravenous every 12 h for 3 days after the insult; n = 6) groups under mechanical ventilation. Results: Five days after the insult, the mean (standard deviation) neurological scores were 10.9 (5.7) in the NT group, 17.0 (0.4) in the TH group (p = 0.025 vs. NT), and 15.0 (3.9) in the TH + EV group. The histopathological score of the TH + EV group showed no significant improvement compared with that of the other groups. Conclusion: TH + EV had no additive neuroprotective effects after hypoxia-ischaemia in neurological and histopathological assessments.

17 October 2024 in European Journal of Medical Genetics
Verified
Journal Article
Open access
MAMakoto Arioka
Makoto Arioka
Shinji NakamuraShinji Nakamura
Shinji Nakamura
KNKatsufumi Nishioka
Katsufumi Nishioka
KIKota Inoue
Kota Inoue
YNYasuhiro Nakao
Yasuhiro Nakao
TKTakashi Kusaka
Takashi Kusaka
Bohring-Opitz syndrome (BOS) is a rare disease with a characteristic facial appearance and limb position. This report describes a case of BOS complicated by persistent pulmonary hypertension of the newborn (PPHN) and formation of abnormal alveoli that was confirmed by autopsy. A female neonate was born by cesarean section at 37 weeks and 2 days of gestation and found to have a nevus flammeus, exophthalmos, abnormal palate, retraction of the mandible, and a posture characteristic of BOS. The patients had severe PPHN requiring inhalation of nitric oxide. Genetic testing revealed a de novo frameshift variant in ASXL1. Autopsy revealed that the lung was at the saccular stage, equivalent to 28-34 weeks of gestation. This is the first report to present pathological evidence of immaturity of the lung that may be associated with PPHN in a patient with BOS caused by a variant in ASXL1.